Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural & Congenital Heart Disease: When TAVR fails | CMS proposes coverage updates, name change for TMVR
Tuesday, July 21, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Top Stories

Worth the wait: After years of trying, researchers 3D print a working heart pump with human cells

The model sits at approximately 1.5 cm long and offers researchers a new way to observe the heart in motion.

READ MORE >
3d printed heart pump
Share on Twitter Share on Facebook Share on Linkedin

Worth the wait: After years of trying, researchers 3D print a working heart pump with human cells

Share on Twitter Share on Facebook Share on Linkedin
3d printed heart pump
The model sits at approximately 1.5 cm long and offers researchers a new way to observe the heart in motion.
READ MORE >

Outcomes ‘worse than expected’ when TAVR fails and surgery is required

The mortality rate was 17% for patients undergoing SAVR following a failed TAVR. 

READ MORE >
surgery-676375_1920.jpg
Share on Twitter Share on Facebook Share on Linkedin

Outcomes ‘worse than expected’ when TAVR fails and surgery is required

Share on Twitter Share on Facebook Share on Linkedin
surgery-676375_1920.jpg
The mortality rate was 17% for patients undergoing SAVR following a failed TAVR. 
READ MORE >

CMS proposes coverage updates, and a name change, for TMVR

CMS has proposed expanding its national coverage policy for transcatheter edge-to-edge repair of the mitral valve so that it includes patients with functional mitral regurgitation. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes coverage updates, and a name change, for TMVR

Share on Twitter Share on Facebook Share on Linkedin
CMS has proposed expanding its national coverage policy for transcatheter edge-to-edge repair of the mitral valve so that it includes patients with functional mitral regurgitation. 
READ MORE >

New polymer heart valve could be a breakthrough for valve replacement surgery

The artificial valve would give clinicians a new option that lasts up to 25 years and does not require prescribing anticoagulation medications.

READ MORE >
heart valve
Share on Twitter Share on Facebook Share on Linkedin

New polymer heart valve could be a breakthrough for valve replacement surgery

Share on Twitter Share on Facebook Share on Linkedin
heart valve
The artificial valve would give clinicians a new option that lasts up to 25 years and does not require prescribing anticoagulation medications.
READ MORE >

Featured Articles

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Share on Twitter Share on Facebook Share on Linkedin
Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.
READ MORE >

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).
READ MORE >

TAVR-related bleeding complications plummet with protamine administration

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

READ MORE >
""
Share on Twitter Share on Facebook Share on Linkedin

TAVR-related bleeding complications plummet with protamine administration

Share on Twitter Share on Facebook Share on Linkedin
""
Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.
READ MORE >

Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

READ MORE >
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
Share on Twitter Share on Facebook Share on Linkedin

Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients

Share on Twitter Share on Facebook Share on Linkedin
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.
READ MORE >

Cardiologist sets sights on improving TAVR outcomes

A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sets sights on improving TAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme